Safe & Easy Environment at Home for Patients Presenting a Frail Syndrome
- Conditions
- Cognitive Deterioration
- Interventions
- Other: Patient's answer without non pharmacological therapeuticOther: Patient's answer with non pharmacological therapeutic
- Registration Number
- NCT02288221
- Lead Sponsor
- Centre Hospitalier Universitaire de Nice
- Brief Summary
All over the world the increasing prevalence of chronic disorders and its impact on functional decline is challenging the sustainability of health care systems. Older individuals also frequently experience the reversible "frailty syndrome", which overlaps with chronic diseases, increasing incidence of disability.
Building a global system aiming to take in charge all causes leading to loss of autonomy is a rather complicated task involving numerous Information and Communication technologies (ICT) solutions which are not always easy to use in everyday life.
The SafEE (Safe Easy Environment) project aim is to improve the safety, autonomy and quality of life of older people at risk.
The SafEE project develop non pharmacological therapeutic through diferent ICT (stimulation aromatherapy automatic fragrance, training interface based on Kinect sensor...) .
The goal of this study is to validate the acceptability, sensitivity and efficacy of the systems.
- Detailed Description
The non pharmacological therapeutic will be install at patient's home :
* aromatherapy,
* music therapy,
* cognitive training in multimedia application offering cognitive games.
Also smart phone will be given to the patient :
* to help him move with a geolocation application,
* to remind him of his daily needs (shopping lists, people to call, etc ...) with an alert apllication.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 4
- Male or female age ≥ 60 years with memory complaint
- Score at the Mini Mental Test (MMSE) ≥ 26.
- Score at the Clinical Dementia Rating Scale (CDR) ≤ 0.5.
- Sensory defect (visual or olfactory) preventing the patient to perfectly meet therapeutic solutions.
- Prescription new psychotropic medication (hypnotic, anxiolytic, antidepressant, antipsychotic) in the week preceding the assessment.
- Subject epileptic.
- Subject vulnerable
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Without non pharmacological therapeutic Patient's answer without non pharmacological therapeutic No change at patient's home With non pharmacological therapeutic Patient's answer with non pharmacological therapeutic Installation of ICT at patient's home
- Primary Outcome Measures
Name Time Method Time spent by the patient using the non-therapeutic solutions 6 months
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Institut Claude Pompidou
🇫🇷Nice, France